Alzheimer's Disease
|
0.300 |
Biomarker
|
disease |
CTD_human |
Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database.
|
17192785 |
2007 |
Presenile dementia
|
0.300 |
Biomarker
|
disease |
CTD_human |
Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database.
|
17192785 |
2007 |
Familial Alzheimer Disease (FAD)
|
0.300 |
Biomarker
|
disease |
CTD_human |
Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database.
|
17192785 |
2007 |
Alzheimer Disease, Late Onset
|
0.300 |
Biomarker
|
disease |
CTD_human |
Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database.
|
17192785 |
2007 |
Acute Confusional Senile Dementia
|
0.300 |
Biomarker
|
disease |
CTD_human |
Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database.
|
17192785 |
2007 |
Alzheimer's Disease, Focal Onset
|
0.300 |
Biomarker
|
disease |
CTD_human |
Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database.
|
17192785 |
2007 |
Alzheimer Disease, Early Onset
|
0.300 |
Biomarker
|
disease |
CTD_human |
Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database.
|
17192785 |
2007 |
Non-obstructive azoospermia
|
0.020 |
Biomarker
|
disease |
BEFREE |
Similarly, expressions of BNC1, TAF7L, YBX2, ODF1, and GAPDHS were significantly decreased in the testis of men with non-obstructive azoospermia (NOZ).
|
31065688 |
2020 |
Non-obstructive azoospermia
|
0.020 |
Biomarker
|
disease |
BEFREE |
Expression analysis of MND1/GAJ, SPATA22, GAPDHS and ACR genes in testicular biopsies from non-obstructive azoospermia (NOA) patients.
|
23675907 |
2013 |
Diabetes Mellitus
|
0.010 |
Biomarker
|
group |
BEFREE |
Based on the literature data on the importance of GAPDS for the motility of sperms in diabetic men, it was concluded that the decrease in the sperm motility and GAPDS activity in the presence of high glucose or diabetes mellitus is due to oxidation of GAPDS and inhibition of glycolysis by the reactive oxygen species produced by sperms.
|
26255202 |
2015 |
Malignant Neoplasms
|
0.010 |
Biomarker
|
group |
BEFREE |
GAPDS showed greater toxicity against cancer cells compared to a known GAPDH enzyme inhibitor.
|
25308277 |
2014 |
Tumor Cell Invasion
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
GAPDS also selectively inhibited cell migration and invasion.
|
25308277 |
2014 |
Primary malignant neoplasm
|
0.010 |
Biomarker
|
group |
BEFREE |
GAPDS showed greater toxicity against cancer cells compared to a known GAPDH enzyme inhibitor.
|
25308277 |
2014 |
melanoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Immunocytochemical staining of melanoma cells revealed native GAPDS in the cytoplasm.
|
23026046 |
2012 |